| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=1uM, Metyrapone, Cytochrome P450 CYP11B1 (Steroid 11-beta Hydroxylase) Inhibitors;Mineralocorticoid Receptor (MR) Antagonists;11-beta-Hydroxysteroid Dehydrogenase Type 1 (11beta-HSD1) Inhibitors targeting CYP11B1, HSD11B1, NR3C2 (Novartis, 4174) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/4174 |
| Similar Terms | |
| Downloads & Tools |
1 genes differentially expressed following the BB-00-UK69_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|
| Symbol | Name | Standardized Value |
|---|---|---|
| LDLR | low density lipoprotein receptor | -0.321762 |